Literature DB >> 19698967

Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.

Edwin J Heeregrave1, Mark J Geels, Jason M Brenchley, Elly Baan, David R Ambrozak, Renee M van der Sluis, Rune Bennemeer, Daniel C Douek, Jaap Goudsmit, Georgios Pollakis, Richard A Koup, William A Paxton.   

Abstract

Viral compartmentalization between naïve and memory CD4(+) T cell subsets has been described, but only for individuals who were receiving antiretroviral therapy (ART). We present here an extensive analysis of the viral quasispecies residing in the naïve, central and effector memory CD4(+) T cell subsets in a number of therapy naïve individuals and representing an array of HIV-1 subtypes. We longitudinally analyzed subset-specific infection and evolution in a subtype B infected individual who switches from CCR5 to dual CCR5/CXCR4 coreceptor usage. We show that the central memory subset, the predominantly infected subset, harbors a more diverse viral population compared to the others. Through sequence analysis of the env C2V3 region we demonstrate a lack of viral compartmentalization among all subsets. Upon coreceptor switch we observe a pronounced increase in the infection level of the naïve population. Our findings emphasize the importance of all CD4(+) T cell subsets to viral evolution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19698967      PMCID: PMC2753733          DOI: 10.1016/j.virol.2009.07.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  61 in total

1.  Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.

Authors:  Georgios Pollakis; Almaz Abebe; Aletta Kliphuis; Moustapha I M Chalaby; Margreet Bakker; Yohannes Mengistu; Margreet Brouwer; Jaap Goudsmit; Hanneke Schuitemaker; William A Paxton
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection.

Authors:  Jennifer A Fulcher; Yon Hwangbo; Rafael Zioni; David Nickle; Xudong Lin; Laura Heath; James I Mullins; Lawrence Corey; Tuofu Zhu
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.

Authors:  Jason M Brenchley; Brenna J Hill; David R Ambrozak; David A Price; Francisco J Guenaga; Joseph P Casazza; Janaki Kuruppu; Javaidia Yazdani; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.

Authors:  Alexey A Nabatov; Georgios Pollakis; Thomas Linnemann; Aletta Kliphius; Moustapha I M Chalaby; William A Paxton
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

6.  Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.

Authors:  Mark J Geels; Marion Cornelissen; Hanneke Schuitemaker; Kiersten Anderson; David Kwa; Jolanda Maas; John T Dekker; Elly Baan; Fokla Zorgdrager; Remco van den Burg; Martijn van Beelen; Vladimir V Lukashov; Tong-Ming Fu; William A Paxton; Lia van der Hoek; Sheri A Dubey; John W Shiver; Jaap Goudsmit
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Productive HIV infection of resting CD4+ T cells: role of lymphoid tissue microenvironment and effect of immunomodulating agents.

Authors:  Audrey Kinter; Anitha Moorthy; Robert Jackson; Anthony S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  2003-10       Impact factor: 2.205

8.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.

Authors:  Bastien Mangeat; Priscilla Turelli; Gersende Caron; Marc Friedli; Luc Perrin; Didier Trono
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

9.  HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.

Authors:  Souheil-Antoine Younes; Bader Yassine-Diab; Alain R Dumont; Mohamed-Rachid Boulassel; Zvi Grossman; Jean-Pierre Routy; Rafick-Pierre Sekaly
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  18 in total

Review 1.  HIV reservoirs and latency models.

Authors:  Matthew J Pace; Luis Agosto; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

2.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

3.  Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.

Authors:  Jennifer M Zerbato; Erik Serrao; Gina Lenzi; Baek Kim; Zandrea Ambrose; Simon C Watkins; Alan N Engelman; Nicolas Sluis-Cremer
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

4.  CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4+ T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and Maintained.

Authors:  Michael Roche; Carolin Tumpach; Jori Symons; Matthew Gartner; Jenny L Anderson; Gabriela Khoury; Kieran Cashin; Paul U Cameron; Melissa J Churchill; Steven G Deeks; Paul R Gorry; Sharon R Lewin
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

5.  Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells.

Authors:  Nina Calantone; Fan Wu; Zachary Klase; Claire Deleage; Molly Perkins; Kenta Matsuda; Elizabeth A Thompson; Alexandra M Ortiz; Carol L Vinton; Ilnour Ourmanov; Karin Loré; Daniel C Douek; Jacob D Estes; Vanessa M Hirsch; Jason M Brenchley
Journal:  Immunity       Date:  2014-09-18       Impact factor: 31.745

6.  CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors.

Authors:  Karen A O'Connell; S Alireza Rabi; Robert F Siliciano; Joel N Blankson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

Review 7.  The HIV-1 env protein: a coat of many colors.

Authors:  Kathryn Twigg Arrildt; Sarah Beth Joseph; Ronald Swanstrom
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

8.  Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.

Authors:  Maria José Duenas-Decamp; Paul J Peters; Alexander Repik; Thomas Musich; Maria Paz Gonzalez-Perez; Catherine Caron; Richard Brown; Jonathan Ball; Paul R Clapham
Journal:  Future Virol       Date:  2010-07       Impact factor: 1.831

9.  Role of Tunneling Nanotube-like Structures during the Early Events of HIV Infection: Novel Features of Tissue Compartmentalization and Mechanism of HIV Spread.

Authors:  George Okafo; Silvana Valdebenito; Maribel Donoso; Ross Luu; David Ajasin; Brendan Prideaux; Santhi Gorantla; Eliseo A Eugenin
Journal:  J Immunol       Date:  2020-10-09       Impact factor: 5.422

10.  Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.

Authors:  Yan Zhang; Catherine de Lara; Andrew Worth; Andrea Hegedus; Karoliina Laamanen; Peter Beverley; Derek Macallan
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.